• Pfizer CEO: 'We do think our stock is undervalued'

    2 days ago - By Up Worthy

    Pfizer's COVID-19 vaccine is nothing short of a blockbuster drug for the company, bringing in $3.5 billion in revenue in the first...
    Read more ...